Mazzoni S - Search Results

1

Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.

Hess B, Kalmuk J, Znoyko I, Schandl CA, Wagner-Johnston N, Mazzoni S, Hendrickson L, Chiad Z, Greenwell IB, Wolff DJ. Hess B, et al. Among authors: mazzoni s. Cancer Genet. 2022 Jan;260-261:18-22. doi: 10.1016/j.cancergen.2021.10.003. Epub 2021 Oct 28. Cancer Genet. 2022. PMID: 34808593 Free PMC article.

2

Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53.

Schandl CA, Mazzoni S, Znoyko I, Nahhas GJ, Chung D, Ding Y, Hess B, Wolff DJ. Schandl CA, et al. Among authors: mazzoni s. Cancer Genet. 2023 Apr;272-273:23-28. doi: 10.1016/j.cancergen.2023.01.004. Epub 2023 Jan 17. Cancer Genet. 2023. PMID: 36657266

3

Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.

Covut F, Ahmed R, Chawla S, Ricaurte F, Samaras CJ, Anwer F, Garcia AVM, Angelini DE, Mazzoni S, Faiman B, Valent J, Khouri J. Covut F, et al. Among authors: mazzoni s. Br J Haematol. 2021 Jun;193(6):1213-1219. doi: 10.1111/bjh.17505. Epub 2021 May 17. Br J Haematol. 2021. PMID: 33997961 Clinical Trial.

4

Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.

Dima D, Hughes M, Orland M, Ullah F, Goel U, Anwer F, Raza S, Mazzoni S, Bhutani D, Williams L, Lentzsch S, Samaras C, Valent J, Chakraborty R, Khouri J. Dima D, et al. Among authors: mazzoni s. Amyloid. 2024 Sep;31(3):195-201. doi: 10.1080/13506129.2024.2366806. Epub 2024 Jul 2. Amyloid. 2024. PMID: 38956891

5

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study.

Jaberi-Douraki M, Xu X, Dima D, Ailawadhi S, Anwer F, Mazzoni S, Valent J, Habib MH, Riviere JE, Raza S. Jaberi-Douraki M, et al. Among authors: mazzoni s. Blood Cancer J. 2024 Dec 20;14(1):223. doi: 10.1038/s41408-024-01206-4. Blood Cancer J. 2024. PMID: 39706832 Free PMC article.

6

Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients.

Rafae A, Ehsan H, Wahab A, Khan SI, Khan I, Ashraf S, Ali S, Khalid F, Neupane K, Valent J, Khouri J, Samaras C, Mazzoni S, Anwer F. Rafae A, et al. Among authors: mazzoni s. Crit Rev Oncol Hematol. 2022 Aug;176:103744. doi: 10.1016/j.critrevonc.2022.103744. Epub 2022 Jun 15. Crit Rev Oncol Hematol. 2022. PMID: 35717005 Review.

7

A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.

Srkalovic G, Hussein MA, Hoering A, Zonder JA, Popplewell LL, Trivedi H, Mazzoni S, Sexton R, Orlowski RZ, Barlogie B. Srkalovic G, et al. Among authors: mazzoni s. Cancer Med. 2014 Oct;3(5):1275-83. doi: 10.1002/cam4.276. Epub 2014 Jun 10. Cancer Med. 2014. PMID: 24913924 Free PMC article. Clinical Trial.

8

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase.

Awada H, Hajj Ali A, Anwer F, Shahzad R, Mazzoni S, Williams L, Chaulagain C, Hamilton B, Sauter C, Khouri J. Awada H, et al. Among authors: mazzoni s. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231177678. doi: 10.1177/10760296231177678. Clin Appl Thromb Hemost. 2023. PMID: 37277999 Free PMC article.

9

Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma.

Lytvynova O, Jwayyed J, Pastel D, Prasad R, Khouri J, Williams L, Mazzoni S, Raza S, Anwer F. Lytvynova O, et al. Among authors: mazzoni s. Antibodies (Basel). 2024 Sep 29;13(4):80. doi: 10.3390/antib13040080. Antibodies (Basel). 2024. PMID: 39449322 Free PMC article. Review.

10

Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer.

Mazzoni S. Mazzoni S. Int Urol Nephrol. 2016 Nov;48(11):1837-1838. doi: 10.1007/s11255-016-1369-x. Epub 2016 Jul 14. Int Urol Nephrol. 2016. PMID: 27417133 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters